INVO Fertility price to sales ratio IVF
Market value divided by revenue over the last twelve months, since 2017.
- Today, Nov 2, 2026
- 0.2×
- 9-year median
- 1.4×
- Against its 9-year history
- 21st
- percentile: 0 is its lowest day, 100 its highest
- 9-year range
- 0.0× to 32.7×
- Peer median
- 0.3×
INVO Fertility's price to sales ratio is 0.2× as of Nov 2, 2026.
That is below its 9-year median of 1.4×, lower than on 79% of days in the last 9 years.
Over that time it ranged from 0.0× in May 2026 to 32.7× in Mar 2018.
The median for 10 medical instruments and supplies stocks of a similar size is 0.3×.
Price to sales ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 0.2× | 0.0× | 0.2× |
| 2025 | 0.1× | 0.0× | 0.3× |
| 2024 | 0.2× | 0.1× | 0.4× |
| 2023 | 0.4× | 0.3× | 1.9× |
| 2022 | 0.4× | 0.3× | 8.1× |
| 2021 | 7.5× | 3.1× | 11.2× |
| 2020 | 3.2× | 0.9× | 15.9× |
| 2019 | 2.2× | 2.1× | 15.5× |
| 2018 | 12.8× | 6.2× | 32.7× |
| 2017 | 8.7× | 8.7× | 19.9× |
Against its peers
Companies in Medical - Instruments & Supplies nearest INVO Fertility's size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| IVFINVO Fertility | 0.2× |
| BBLGBone Biologics | n/m |
| TNONTenon Medical | 0.2× |
| VJETFlyte Aviation | 0.4× |
| AMIXAutonomix Medical | n/m |
| NXGLNexgel | n/m |
| ADGMAdagio Medical | n/a |
| XAIRBeyond Air | 0.3× |
| VVOSVivos Therapeutics | 0.1× |
| CODXCo-Diagnostics | 3.1× |
| BJDXBluejay Diagnostics | n/m |
| Peer median | 0.3× |
Where INVO Fertility ranks
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on INVO Fertility
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.